Nomura Holdings
PGNX

Nomura Holdings’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Nomura Holdings’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-46,295
Closed -$277K – 2143
2015
Q1 		$277K Buy
+46,295
New +$291K ﹤0.01% 1374
2014
Q1 		– Sell
-30,800
Closed -$164K – 2993
2013
Q4 		$164K Buy
+30,800
New +$135K ﹤0.01% 1789
2013
Q3 		– Sell
-44,512
Closed -$199K – 2698
2013
Q2 		$199K Buy
+44,512
New +$200K ﹤0.01% 1851

Other funds holding PGNX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nomura Holdings's PGNX Position: Q2 2015 in Review

Nomura Holdings sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2015, closing a stake of 46,295 shares — an estimated $277K sold.

Nomura Holdings first reported a position in PGNX in Q2 2013 and held it in 3 quarters. The position peaked at $277K in Q1 2015. 121 funds tracked by Wall St. Rank hold PGNX as of Q2 2015.

  • Nomura Holdings reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • Nomura Holdings sold 46,295 Progenics Pharmaceuticals Inc shares in Q2 2015, an estimated $277K.
  • Nomura Holdings first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • Nomura Holdings's Progenics Pharmaceuticals Inc position peaked at $277K in Q1 2015.
  • 121 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2015.

Based on Nomura Holdings's 13F filing for Q2 2015, filed 14 Aug 2015.